Anti-Protozoan Activities of Polar Fish-Derived Polyalanine Synthetic Peptides
Chagas disease, sleeping sickness and malaria are infectious diseases caused by protozoan parasites that kill millions of people worldwide. Here, we performed in vitro assays of Pa-MAP, Pa-MAP1.9, and Pa-MAP2 synthetic polyalanine peptides derived from the polar fish Pleuronectes americanus toward Trypanosoma cruzi, T. brucei gambiense and Plasmodium falciparum activities. We demonstrated that the peptides Pa-MAP1.9 and Pa-MAP2 were effective to inhibit T. brucei growth. In addition, structural analyses using molecular dynamics (MD) studies showed that Pa-MAP2 penetrates deeper into the membrane and interacts more with phospholipids than Pa-MAP1.9, corroborating the previous in vitro results showing that Pa-MAP1.9 acts within the cell, while Pa-MAP2 acts via membrane lysis. In conclusion, polyalanine Pa-MAP1.9 and Pa-MAP2 presented activity against bloodstream forms of T. b. gambiense, thus encouraging further studies on the application of these peptides as a treatment for sleeping sickness.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Marine drugs - 21(2023), 8 vom: 31. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nunes, Ellynes Amancio Correia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
25191-17-7 |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 02.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/md21080434 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361219636 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361219636 | ||
| 003 | DE-627 | ||
| 005 | 20231226084659.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/md21080434 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1204.xml |
| 035 | |a (DE-627)NLM361219636 | ||
| 035 | |a (NLM)37623715 | ||
| 035 | |a (PII)434 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nunes, Ellynes Amancio Correia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anti-Protozoan Activities of Polar Fish-Derived Polyalanine Synthetic Peptides |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 02.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Chagas disease, sleeping sickness and malaria are infectious diseases caused by protozoan parasites that kill millions of people worldwide. Here, we performed in vitro assays of Pa-MAP, Pa-MAP1.9, and Pa-MAP2 synthetic polyalanine peptides derived from the polar fish Pleuronectes americanus toward Trypanosoma cruzi, T. brucei gambiense and Plasmodium falciparum activities. We demonstrated that the peptides Pa-MAP1.9 and Pa-MAP2 were effective to inhibit T. brucei growth. In addition, structural analyses using molecular dynamics (MD) studies showed that Pa-MAP2 penetrates deeper into the membrane and interacts more with phospholipids than Pa-MAP1.9, corroborating the previous in vitro results showing that Pa-MAP1.9 acts within the cell, while Pa-MAP2 acts via membrane lysis. In conclusion, polyalanine Pa-MAP1.9 and Pa-MAP2 presented activity against bloodstream forms of T. b. gambiense, thus encouraging further studies on the application of these peptides as a treatment for sleeping sickness | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a antimicrobial peptide | |
| 650 | 4 | |a antiplasmodial peptide | |
| 650 | 4 | |a molecular dynamics | |
| 650 | 4 | |a polyalanine | |
| 650 | 4 | |a trypanocidal peptide | |
| 650 | 7 | |a polyalanine |2 NLM | |
| 650 | 7 | |a 25191-17-7 |2 NLM | |
| 650 | 7 | |a Peptides |2 NLM | |
| 700 | 1 | |a da Silva, Maria Cláudia |e verfasserin |4 aut | |
| 700 | 1 | |a Cardoso, Marlon Henrique |e verfasserin |4 aut | |
| 700 | 1 | |a Preza, Sergio Leandro Espíndola |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira, Lucas Silva |e verfasserin |4 aut | |
| 700 | 1 | |a Frihling, Breno Emanuel Farias |e verfasserin |4 aut | |
| 700 | 1 | |a Charneau, Sébastien Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Grellier, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Franco, Octávio Luiz |e verfasserin |4 aut | |
| 700 | 1 | |a Migliolo, Ludovico |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Marine drugs |d 2007 |g 21(2023), 8 vom: 31. Juli |w (DE-627)NLM179368389 |x 1660-3397 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2023 |g number:8 |g day:31 |g month:07 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/md21080434 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2023 |e 8 |b 31 |c 07 | ||